fbpx
0f9407626e83ba22b

(March 30, 2022) Webinar: Imaging Hypoxia

Overview: In this webinar, Katie will discuss the role hypoxia plays in disease progression and treatment response, specifically in cancer. She will also dive into the various molecular imaging technologies that can be used to visualize and assess hypoxia in preclinical cancer models. Some modalities that will be covered include magnetic resonance imaging (MRI), positron

By |2022-03-29T14:04:58-04:00February 14th, 2022|Tags: , , , |Comments Off on (March 30, 2022) Webinar: Imaging Hypoxia

(May 10, 2022) Webinar: Different Modalities to Study Mechanisms of Hemorrhagic Stroke in A Rat Model

Overview: Hemorrhagic stroke occurrence is functionally partially based on the diet, underlying disease states, nutritional availability, and potential presence of chronic inflammatory disease. We will look at the potential mechanisms of cerebrovascular dysfunction that lead to hemorrhagic stroke, potential physiological alterations, and possible methods of treatment in preclinical studies. The webinar will investigate these questions

By |2022-04-08T14:30:22-04:00January 18th, 2022|Tags: , |Comments Off on (May 10, 2022) Webinar: Different Modalities to Study Mechanisms of Hemorrhagic Stroke in A Rat Model

(December 2, 2021) The Bench to Bedside Series: Preclinical Cancer Research with Scintica

In this webinar we will discuss the following topics: • Introduction To Cancer Research • What does “Bench to Bedside” mean? • In vitro characterization • Rapid throughput screening • Quantitative tools • Moving towards translation Overview: The goal of this webinar will be to provide a high-level overview of the various stages of preclinical

By |2022-01-07T11:11:29-05:00November 2nd, 2021|Tags: , , , |Comments Off on (December 2, 2021) The Bench to Bedside Series: Preclinical Cancer Research with Scintica

Registration for Webinar: GSK3 Inhibition and Muscle Wasting Disorders: Muscular Dystrophy and Spaceflight (October 27, 2021)

Thank you for showing interest in our webinar titled: GSK3 Inhibition and Muscle Wasting Disorders: Muscular Dystrophy and Spaceflight Once registered you will receive the webinar link and password via email. We will be sending out a copy of the presentation after the day of the webinar.  

By |2021-09-29T14:12:17-04:00September 29th, 2021|Categories: Animal Models, DEXA, Imaging, Mouse, Rat|Tags: , , |Comments Off on Registration for Webinar: GSK3 Inhibition and Muscle Wasting Disorders: Muscular Dystrophy and Spaceflight (October 27, 2021)

(October 27, 2021) Webinar: GSK3 Inhibition and Muscle Wasting Disorders: Muscular Dystrophy and Spaceflight

Overview: Muscles are vital for everyday life, from every move we make to every beat of the heart. Conditions that lead to muscle wasting can drastically reduce our health and quality of life. This presentation will discuss the possibility of inhibiting an enzyme called glycogen synthase kinase 3 (GSK3) for the treatment/management of muscular dystrophy

By |2021-09-29T14:19:14-04:00September 22nd, 2021|Tags: , , , , |Comments Off on (October 27, 2021) Webinar: GSK3 Inhibition and Muscle Wasting Disorders: Muscular Dystrophy and Spaceflight
Go to Top